Holmes E C, Morton D L
Orthop Clin North Am. 1977 Oct;8(4):805-10.
We use pulmonary resection in patients with metastatic disease confined to the lungs when the primary disease is controlled, when the tumor doubling time of metastases is longer than 40 days, and when there is no evidence of metastases to other viscera. A staged bilateral thoracotomy should be performed when necessary. The size of the lesions and the number of lesions are not contraindications for resection. Pneumonectomy has been performed with gratifying long term results. Treatment in patients who have rapidly progressive metastatic lesions (tumor doubling time less than 40 days) or who have other metastatic disease must be considered experimental. Chemotherapeutic regimens used as adjuncts to pulmonary resection may produce extreme toxicity in this group of patients. This form of therapy must be administered and followed by experienced personnel in a medical center with facilities for close supervision.
当原发疾病得到控制、转移瘤的肿瘤倍增时间超过40天且无其他内脏转移证据时,我们会对局限于肺部的转移性疾病患者进行肺切除术。必要时应进行分期双侧开胸手术。病变大小和病变数量并非手术切除的禁忌证。全肺切除术已取得了令人满意的长期效果。对于有快速进展性转移瘤(肿瘤倍增时间少于40天)或有其他转移疾病的患者,治疗必须被视为试验性的。作为肺切除辅助手段的化疗方案在这类患者中可能会产生极大毒性。这种治疗形式必须由经验丰富的人员在具备密切监测设施的医疗中心进行实施和随访。